Schedule of earnings (loss) per share |
The calculation of income (loss) per
share for the three and six months ended September 30, 2020, and 2019 was as follows:
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) before Discontinued Operations |
|
$ |
(2,056,508 |
) |
|
$ |
(1,038,732 |
) |
|
$ |
(3,651,140 |
) |
|
$ |
(2,326,330 |
) |
Discontinued Operations |
|
|
— |
|
|
|
761,768 |
|
|
|
— |
|
|
|
761,768 |
|
Net (Loss) |
|
|
(2,056,508 |
) |
|
|
(276,964 |
) |
|
|
(3,651,140 |
) |
|
|
(1,564,562 |
) |
Less preferred dividends |
|
|
(1,651,219 |
) |
|
|
(1,893,886 |
) |
|
|
(3,331,975 |
) |
|
|
(3,771,941 |
) |
Net loss attributable to common stockholders |
|
$ |
(3,707,727 |
) |
|
$ |
(2,170,850 |
) |
|
$ |
(6,983,115 |
) |
|
$ |
(5,336,503 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Weighted average share – basic |
|
|
19,815,872 |
|
|
|
493,300 |
|
|
|
13,705,461 |
|
|
|
259,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of common stock equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options/warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Preferred C shares |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Weighted average shares – diluted |
|
|
19,815,872 |
|
|
|
493,300 |
|
|
|
13,705,461 |
|
|
|
259,432 |
|
Income (loss) per share – basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
(0.19 |
) |
|
$ |
(5.94 |
) |
|
$ |
(0.51 |
) |
|
$ |
(23.51 |
) |
Discontinued Operations |
|
|
— |
|
|
|
1.54 |
|
|
|
— |
|
|
|
2.94 |
|
Total |
|
|
(0.19 |
) |
|
|
(4.40 |
) |
|
|
(0.51 |
) |
|
|
(20.57 |
) |
Income (loss) per share – diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing Operations |
|
$ |
(0.19 |
) |
|
$ |
(5.94 |
) |
|
$ |
(0.51 |
) |
|
$ |
(23.51 |
) |
Discontinued Operations |
|
|
— |
|
|
|
1.54 |
|
|
|
— |
|
|
|
2.94 |
|
Total |
|
|
(0.19) |
|
|
|
(4.40 |
) |
|
|
(0.51 |
) |
|
|
(20.57 |
) |
|
Schedule of anti-dilutive shares |
For the three and six months
ended September 30, 2020, and 2019, the following share equivalents related to convertible debt and warrants to purchase shares
of common stock were excluded from the computation of diluted net income (loss) per share as the inclusion of such shares
would be anti-dilutive.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
Common Shares Issuable for: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Debt |
|
|
276 |
|
|
|
276 |
|
|
|
276 |
|
|
|
276 |
|
Options and Warrants |
|
|
38 |
|
|
|
38 |
|
|
|
38 |
|
|
|
38 |
|
Series C Preferred Shares(1)
|
|
|
47,033,410,723 |
|
|
|
1,130,378,205 |
|
|
|
47,033,410,723 |
|
|
|
1,130,378,205 |
|
Total |
|
|
47,033,411,037 |
|
|
|
1,130,378,519 |
|
|
|
47,033,411,037 |
|
|
|
1,130,378,519 |
|
|
(1) |
Based on the lowest possible conversion rate of the Series C Preferred Stock ($0.001 per share, the par value of the common stock). |
|